OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study
Nabeela Siddeeque, Mohammad H. Hussein, Ahmed Abd‐Elmaksoud, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113537-113537
Open Access | Times Cited: 7
Nabeela Siddeeque, Mohammad H. Hussein, Ahmed Abd‐Elmaksoud, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113537-113537
Open Access | Times Cited: 7
Showing 7 citing articles:
Mads Gamborg, Mia Klinten Grand, Jasmin Arvedsen, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology
Melania Gaggini, Laura Sabatino, Adrian Florentin Suman, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 387-387
Open Access
Melania Gaggini, Laura Sabatino, Adrian Florentin Suman, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 387-387
Open Access
Glucagon-like-peptide-1-Rezeptoragonisten: eine neue pharmakologische Behandlungsoption für psychiatrische Erkrankungen?
Hubertus Himmerich
Der Nervenarzt (2025)
Open Access
Hubertus Himmerich
Der Nervenarzt (2025)
Open Access
Semaglutide to remodel mitochondrial dynamics and mitophagy balance for vascular dementia therapy
Xiaoyan Yang, Peng Feng, Hongxu Zhu, et al.
View (2025)
Open Access
Xiaoyan Yang, Peng Feng, Hongxu Zhu, et al.
View (2025)
Open Access
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health
Mohamad Al Qassab, M.A. Mneimneh, Ahmad Jradi, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 285-285
Open Access
Mohamad Al Qassab, M.A. Mneimneh, Ahmad Jradi, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 285-285
Open Access
The Critical Role of GLP-1 Signaling Pathways in the Pathology of Parkinson's Disease and Diabetes
Jinhao Chen, Xiang Dong, Yi-Chen Lin, et al.
Pathology - Research and Practice (2025), pp. 155985-155985
Closed Access
Jinhao Chen, Xiang Dong, Yi-Chen Lin, et al.
Pathology - Research and Practice (2025), pp. 155985-155985
Closed Access
Linking Metabolic Syndrome to Neurodegeneration Mechanisms and Potential Treatments
Amina Džidić-Krivić, Almir Fajkić, Esma Karahmet Farhat, et al.
Molecular Neurobiology (2025)
Closed Access
Amina Džidić-Krivić, Almir Fajkić, Esma Karahmet Farhat, et al.
Molecular Neurobiology (2025)
Closed Access
Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy
James H. O’Keefe, William Grant Franco, Evan L. O’Keefe
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 3
James H. O’Keefe, William Grant Franco, Evan L. O’Keefe
Progress in Cardiovascular Diseases (2024)
Closed Access | Times Cited: 3
